State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

Commentary
Article

In Partnership With:

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

Speakers

  • Catherine E. Lai, MD, MPH | Penn Medicine
  • Elizabeth Olson Hexner, MD | Penn Medicine
  • Pashna N. Mushni, MD | Penn Medicine
  • Daria V. Babushok, MD, PhD | Penn Medicine
  • Ximena Jordan Bruno, MD | Penn Medicine
  • Elise A. Chong, MD | Penn Medicine

Topics

  • Treatment of Patients With Myelofibrosis
  • Current and Future Treatments for Chronic GVHD
  • Treatment Pathways for Patients With PNH
  • Emerging Treatment Standards for MDS
  • Sequencing BTK Inhibitors in CLL
  • Therapeutic Approaches to AML

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Lori A. Leslie, MD
Changchun Deng, MD, PhD
David L. Porter, MD, director, Cell Therapy and Transplant, Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Penn Medicine
Guenther Koehne, MD, PhD
Ibrahim Aldoss, MD
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University
Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Ibrahim Aldoss, MD
Kateryna Fedorov, MD, assistant professor, hematology-oncology, Vanderbilt University Medical Center
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute